Stockholm, Sweden

Britt I Keding


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Britt I Keding: Innovator in Pharmaceutical Chemistry

Introduction

Britt I Keding is a notable inventor based in Stockholm, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds.

Latest Patents

Keding holds a patent for a process titled "Process for S-metoprolol via oxazolidin-2-one." This innovative method describes the preparation of S-metoprolol, a compound known for its high enantiomeric purity. The process involves the preparation of a specific sulfonic acid ester, which is then reacted with 4-[2-methoxyethyl]phenol. The resulting intermediate undergoes hydrolysis to yield S-metoprolol. This patent showcases Keding's expertise in creating efficient and effective pharmaceutical processes.

Career Highlights

Britt I Keding is currently employed at Astra Pharmaceutical Production Aktiebolag, where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the production methods of various pharmaceutical compounds.

Collaborations

Keding has collaborated with esteemed colleagues, including Bo A Lindqvist and Bengt Bertil Samuelsson. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of knowledge within the pharmaceutical industry.

Conclusion

Britt I Keding's contributions to pharmaceutical chemistry, particularly through her patent for S-metoprolol, highlight her role as a leading inventor in her field. Her work at Astra Pharmaceutical Production Aktiebolag and collaborations with other professionals further emphasize her commitment to advancing pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…